Keros Therapeutics (KROS) Non-Current Assets (2019 - 2026)
Keros Therapeutics' Non-Current Assets came in at $20.72 million for Q2 2026, down 14.9% from $24.36 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Keros Therapeutics' Non-Current Assets was $22.59 million, down 16.3% from FY2024.
- Non-Current Assets carries a five-year compound annual growth rate of 67.4% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $26.99 million in FY2024 (+18.7%), $22.73 million in FY2023 (+8.2%), $21.01 million in FY2022 (+451.4%) and $3.81 million in FY2021 (+122.0%).
- The Q2 2026 figure represents the lowest quarterly Non-Current Assets since Q3 2022.
- Year-over-year, Non-Current Assets increased in four of the last seven quarters, with growth averaging 2.6%.
- The fastest year-over-year change in Non-Current Assets over five years came in Q1 2023 (growth of 466.4%), and the weakest in Q4 2025 (a decline of 16.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Keros Therapeutics | 185.02 Mn | -900.96 Mn | - | 19.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 19.74 Mn |
| Jun 30, 2026 | 20.72 Mn |
| Mar 31, 2026 | 21.62 Mn |
| Dec 31, 2025 | 22.59 Mn |
| Sep 30, 2025 | 23.48 Mn |
| Jun 30, 2025 | 24.36 Mn |
| Mar 31, 2025 | 25.05 Mn |
| Dec 31, 2024 | 26.99 Mn |
| Sep 30, 2024 | 27.23 Mn |
| Jun 30, 2024 | 22.31 Mn |
| Mar 31, 2024 | 22.69 Mn |
| Dec 31, 2023 | 22.73 Mn |
| Sep 30, 2023 | 21.81 Mn |
| Jun 30, 2023 | 22.00 Mn |
| Mar 31, 2023 | 22.21 Mn |
| Dec 31, 2022 | 21.01 Mn |
| Sep 30, 2022 | 6.68 Mn |
| Jun 30, 2022 | 4.30 Mn |
| Mar 31, 2022 | 3.92 Mn |
| Dec 31, 2021 | 3.81 Mn |
API Access
Keros Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();